Rosettapath

A science-based pathology consultancy providing experimental and toxicologic pathology expertise for the life science industries: biotech, pharmaceutical, contract research organisations and AI / image analysis sectors. Using digital pathology and application of pathology artificial intelligence tools, to advise on safety and efficacy of new candidate medicines. A trusted partner who helps advance projects by applying nonclinical expertise to risk assessment. Provide help on regulatory interactions to aid product registration. Services: • Primary microscopic examination, interpretation and reporting of slides or whole slide images of efficacy and safety studies • Peer review of efficacy and safety studies • Outsourced project pathologist role- providing continuity and application of project knowledge through discovery into development. • Strategic input on investigative approaches and mitigation plan for potential safety liabilities identified from target safety reviews to late stage development • Provide expert input to responses to regulatory questions concerning pathology findings